SAN FRANCISCO / Dec 17, 2024 / Business Wire / Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released its State of Telemedicine Report, showing that 83% of physician telemedicine users surveyed would like virtual care to remain a permanent part of their clinical practice. Among physicians surveyed, 84% highlighted telemedicine’s value in improving continuity of care for patients with chronic or complex conditions, and 96% emphasized its role as a complement to or, depending on the patient, a replacement for in-person care.
As part of the study, Doximity analyzed the adoption of its telemedicine tools across its physician membership and surveyed both physician telemedicine users and patients about their experiences.* Both physicians and patients reported telemedicine has increased access to health care services and strengthened physician-patient communications. The majority of physicians also reported telemedicine has contributed to better disease management, improved patient outcomes and satisfaction, and better or equivalent adherence to treatment plans.
“While in-person care continues to be a cornerstone of health care delivery, telemedicine serves as a valuable complement to this care,” said Nate Gross, MD, co-founder and chief strategy officer at Doximity. “Findings from this study indicate that telemedicine and in-person care are allies, not competitors, in providing timely, comprehensive, and patient-focused care.”
Key Findings from Physician Survey:
Key Findings from Patient Survey:
For more information, view Doximity’s State of Telemedicine Report.
About Doximity
Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. Doximity's mission is to help doctors be more productive so they can provide better care for their patients.
*Doximity surveyed more than 1,100 physicians across ten specialties and, for the first time, surveyed more than 130 nurse practitioners. Doximity also surveyed 2,400 adult patients.
Last Trade: | US$53.73 |
Daily Change: | 0.34 0.64 |
Daily Volume: | 175,037 |
Market Cap: | US$6.880B |
November 07, 2024 October 31, 2024 August 08, 2024 |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORECue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB